Literature DB >> 21458240

The facts of schizophrenia: a personal commentary.

William T Carpenter1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21458240     DOI： 10.1016/j.schres.2011.03.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.

Authors:  Anne Schmechtig; Jane Lees; Lois Grayson; Kevin J Craig; Rukiya Dadhiwala; Gerard R Dawson; J F William Deakin; Colin T Dourish; Ivan Koychev; Katrina McMullen; Ellen M Migo; Charlotte Perry; Lawrence Wilkinson; Robin Morris; Steve C R Williams; Ulrich Ettinger
Journal:  Psychopharmacology (Berl)       Date:  2013-02-22       Impact factor: 4.530

Review 2.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

3.  Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.

Authors:  Gemma L Dalton; Stan B Floresco; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2021-01-11       Impact factor: 4.530

Review 4.  Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?

Authors:  Milica Milovan Borovcanin; Ivan Jovanovic; Gordana Radosavljevic; Jelena Pantic; Slavica Minic Janicijevic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Front Psychiatry       Date:  2017-11-06       Impact factor: 4.157

Review 5.  The concept of schizotypy - A computational anatomy perspective.

Authors:  C Modenato; B Draganski
Journal:  Schizophr Res Cogn       Date:  2015-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.